Safety Study of NNZ-2566 in Healthy Subjects, Following Oral Administration
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain evidence of safety and determine the pharmacokinetics
(PK) of NNZ-2566 in healthy volunteers, when administered orally.